The Development of a Mobile-based App to Increase Uptake of Pre-Exposure Prophylaxis (PrEP) by Men Who Have Sex With Men in China

Not Applicable

Completed

• Conditions: HIV; Pre-exposure Prophylaxis
• Interventions: Behavioral: Phone application

• Registration Number: NCT04426656
• Lead Sponsor: University of North Carolina, Chapel Hill

Brief Summary

This study aims to use a mini-application on the popular Chinese social media mobile platform, WeChat, to improve HIV pre-exposure prophylaxis (PrEP) uptake among at-risk men who have sex with men (MSM). UNC investigators will work in close partnership with a well-established HIV special hospital and the local MSM community to understand key barriers to PrEP use, and develop a mobile-based intervention to increase PrEP uptake among young MSM in Guangzhou, China.

Detailed Description

This study includes two parts. Before the start of Part 1, a mini-app prototype for promoting HIV pre-exposure prophylaxis (PrEP) uptake will have been developed from a prior MSM community-driven hackathon contest. PrEP is an antiretroviral medicines-based prevention strategy against HIV infection, which has been proved save and effective.

Part 1 includes in-depth interviews with 40 HIV-negative young MSM (18 and above) with a brief survey to collect demographic data. The interview topics include PrEP-related perceptions and feedback on the design of a mini-app prototype. Findings from Part 1 will inform refining the mini-app before the start of Part 2.

In Part 2, a small two-arm randomized control trial with 70 young MSM (18 and above) will be conducted to evaluate the preliminary efficacy of the mini-app in improving PrEP-related perceptions and actual PrEP uptake, compared to a control group of standard of care.

Participants in Part 2 will be followed up for 12 weeks (8 week intervention and after-intervention follow-up at 12th week). A subgroup of participants (n=15) from both the intervention arm and the control arm will receive two rounds of in-depth interviews, separately at the 4th and 8th week, to share their experience of using the app and changed perceptions and/or behaviors related to PrEP.

Study Timeline

• Study First Submitted: 2020-06-08
• Study First Submitted QC: 2020-06-08
• Study First Posted: 2020-06-11
• Study Start: 2020-07-08
• Primary Completion: 2021-04-02
• Study Completion: 2021-04-02
• Status Verified: 2022-01
• Results First Submitted: 2022-01-31
• Results First Submitted QC: 2022-02-28
• Last Update Submitted: 2022-02-28
• Results First Posted: 2022-03-02
• Last Update Posted: 2022-03-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 70

Inclusion Criteria

• Part 1: HIV-negative men who have sex with men (MSM): must self-report: being assigned male sex at birth, HIV-negative, age 18 and above, ever having had anal sex with another man, identify as a Chinese citizen, own a smartphone, able to being willing to sign written informed consent and participate in the study as procedures required.

Part 2: HIV-negative men who have sex with men (MSM): same characteristics as in Part 1.

AND, they must report :

• Having a smartphone with WeChat installed.

• Being assigned male sex at birth, HIV-negative, age 18 and above, ever having had anal sex with another man, currently reside in Guangzhou, China, identifying as a Chinese citizen, able to sign written informed consent and participate in the study as procedures require. AND

• At least one criterion associated with high risk of HIV infection in the past 6 months prior to enrollment as follows:

  • Unprotected (condomless) anal intercourse with male partner(s)
  • More than two male partners (regardless of condom use and HIV serostatus)
  • Reported STI, such as syphilis, Herpes Simplex Virus-2 (HSV-2), gonorrhea, chlamydia, chancroid, or lymphogranuloma venereum.
  • Reported use of post-exposure prophylaxis (PEP)
  • Have a sexual partner living with HIV

Read More

Exclusion Criteria

• Part 1: Individuals who report any following status will be excluded from participating Part 1:

  • HIV-positive
  • Mental health issues which may compromise participant adherence or safety, including memory loss, cognitive impairment, intellectual disability, or communication disorders.

• Part 2:

  • HIV-positive (self-report or lab-confirmed)
  • Currently taking oral PrEP based on self-report
  • Symptoms of acute HIV infection within the prior 30 days
  • Contradictions to taking oral PrEP
  • Personal diagnosis or family history of hemophilia
  • Chronic Hepatitis B (self-report)
  • Participating in another research study related to HIV and antiretroviral therapy or other intervention study
  • Having serious chronic disease, including metabolic diseases (such as diabetes), neurological, and psychiatric disorders
  • Mental health issues which may compromise participant adherence or safety, including memory loss, cognitive impairment, intellectual disability, or communication disorders

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Part 2 mini-app	Phone application	In addition to the standard of care, participants in the mini-app arm will have access to the mini-app (i.e. the intervention) during the whole study period.

Primary Outcome Measures

Name	Time	Method
Number of Participants at Different Change Stages to PrEP Initiation at Week 4	Week 4	Individual's stages in the changing process towards starting using PrEP, which includes pre-contemplation (no interest in using PrEP), contemplation (interested in using PrEP but no action taken), preparation (plan to start PrEP and have taken initial actions), action (have started using PrEP), and maintenance (stay adherent to PrEP regimen). Each stage will be assessed by 1 or 2 questions (Yes/No) to determine which stage the individual is currently at.
Number of Participants at Different Change Stages to PrEP Initiation at Week 12	Week 12	Individual's stages in the changing process towards starting using PrEP, which includes pre-contemplation (no interest in using PrEP), contemplation (interested in using PrEP but no action taken), preparation (plan to start PrEP and have taken initial actions), action (have started using PrEP), and maintenance (stay adherent to PrEP regimen). Each stage will be assessed by 1 or 2 questions (Yes/No) to determine which stage the individual is currently at.
Change in Intention to Use PrEP Score	Baseline and up to 12 weeks	Individual perceived likelihood to start using PrEP, measured by a one-item question with a bipolar response scale (-3 to 3). Higher score indicates higher intention to use.
Number of Participants at Different Change Stages to PrEP Initiation at Week 8	Week 8	Individual's stages in the changing process towards starting using PrEP, which includes pre-contemplation (no interest in using PrEP), contemplation (interested in using PrEP but no action taken), preparation (plan to start PrEP and have taken initial actions), action (have started using PrEP), and maintenance (stay adherent to PrEP regimen). Each stage will be assessed by 1 or 2 questions (Yes/No) to determine which stage the individual is currently at.
Number of Participants Who Initiate PrEP by Week 8	Up to 8 weeks	Individual's self-reported whether starting use of PrEP medication (binary: Yes/No)
Number of Participants at Different Change Stages to PrEP Initiation at Baseline	Baseline	Individual's stages in the changing process towards starting using PrEP, which includes pre-contemplation (no interest in using PrEP), contemplation (interested in using PrEP but no action taken), preparation (plan to start PrEP and have taken initial actions), action (have started using PrEP), and maintenance (stay adherent to PrEP regimen). Each stage will be assessed by 1 or 2 questions (Yes/No) to determine which stage the individual is currently at.

Secondary Outcome Measures

Name	Time	Method
Change in PrEP Self-Efficacy Score	Baseline and up to 12 weeks	Self-Efficacy will be assessed at Baseline, Weeks 4, 8, and 12 using an 8-item PrEP self-efficacy scale. Values range from 0-5. Higher scores indicate higher self-efficacy to use PrEP.
Number of Participants Who Are Willing to Pay a Specified Percentage of Monthly Income for PrEP	Up to 12 weeks	Willingness to pay for PrEP ranging from 0-100% of monthly income. Amount spent will be assessed at Baseline, Weeks 4, 8, and 12.
Change in PrEP Stigma Score	Baseline and up to 12 weeks	Individual's perceived stigma related to PrEP, measured by 5-item PrEP stigma scale. Values range from 0-5. Higher score indicates higher perceived stigma related to PrEP. The PrEP Stigma will be assessed at Baseline, Weeks 4, 8, and 12.
Change in PrEP Knowledge Score at Week 4, 8 and 12	Baseline and up to 12 weeks	Individual's understanding of PrEP, measured by a 5-item True/False quiz. Values range from 0-5. Higher score indicates better PrEP knowledge.
Change in PrEP Attitude Score	Baseline and up to 12 weeks	Individual's attitude towards PrEP, measured by a 5-item scale. Values range from 0-5. Higher scores indicate more positive attitude toward PrEP. The PrEP Attitude will be assessed at Baseline, Weeks 4, 8, and 12.
Number of Participants Who Ordered At-home HIV/Syphilis Tests	12 weeks	Number of participants who ordered at-home HIV/syphilis tests through the mini-app based on the study record. Values range from 0 to greater than 0. Higher indicates higher frequency of participants who ordered HIV/syphilis tests completed through the study.

Trial Locations

Locations (1)

Guangzhou No. 8 People's Hospital; 🇨🇳 Guangzhou, China